- Home
- Publications
- Publication Search
- Publication Details
Title
Familial hypercholesterolaemia
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17093
Publisher
Springer Nature
Online
2017-12-07
DOI
10.1038/nrdp.2017.93
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?
- (2017) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Recent advances in genetic testing for familial hypercholesterolemia
- (2017) Michael A. Iacocca et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia
- (2017) Martine Paquette et al. Journal of Clinical Lipidology
- Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE
- (2017) Martine Paquette et al. Journal of Clinical Lipidology
- Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia
- (2017) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association
- (2017) Carl E. Orringer et al. Journal of Clinical Lipidology
- Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations
- (2017) Evan A. Stein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?
- (2017) Francesco Sbrana et al. European Journal of Preventive Cardiology
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
- (2017) Li Jun Qian et al. Scientific Reports
- Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial HypercholesterolaemiaHighlights
- (2016) Leopoldo Pérez de Isla et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained ClinicallyHighlights
- (2016) Jian Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
- (2016) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS SUPPLEMENTS
- Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesClinical Perspective
- (2016) David Nanchen et al. CIRCULATION
- Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia PhenotypeClinical Perspective
- (2016) Amanda M. Perak et al. CIRCULATION
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Drugs for hypercholesterolaemia - from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition
- (2016) A. S. Wierzbicki et al. CLINICAL MEDICINE
- Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?
- (2016) Jeffrey E. Alfonsi et al. Current Atherosclerosis Reports
- New oral agents for treating dyslipidemia
- (2016) Steven E. Gryn et al. CURRENT OPINION IN LIPIDOLOGY
- Combined hyperlipidemia
- (2016) Amanda J. Brahm et al. CURRENT OPINION IN LIPIDOLOGY
- Bile salts in control of lipid metabolism
- (2016) Marleen Schonewille et al. CURRENT OPINION IN LIPIDOLOGY
- Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia
- (2016) Paula Lozano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Examining barriers to cascade screening for familial hypercholesterolemia in the United States
- (2016) Rolf Andersen et al. Journal of Clinical Lipidology
- Familial defective apolipoprotein B-100: A review
- (2016) Lars H. Andersen et al. Journal of Clinical Lipidology
- Determining When to Add Nonstatin Therapy
- (2016) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
- (2016) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins in Familial Hypercholesterolemia
- (2016) Joost Besseling et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Child–Parent Familial Hypercholesterolemia Screening in Primary Care
- (2016) David S. Wald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
- (2016) Anthony Wang et al. Journal of the American Heart Association
- Familial hypercholesterolaemia: beware of lipoprotein(a)
- (2016) Raul D Santos Lancet Diabetes & Endocrinology
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
- (2016) Anne Langsted et al. Lancet Diabetes & Endocrinology
- Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement FromATVBCouncil: Table.
- (2015) Robert A. Hegele et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
- (2015) Stephen F. Weng et al. ATHEROSCLEROSIS
- Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience
- (2015) Damon A. Bell et al. ATHEROSCLEROSIS
- Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales
- (2015) K. Haralambos et al. ATHEROSCLEROSIS
- Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology
- (2015) Guy De Backer et al. ATHEROSCLEROSIS
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- Characterization of Autosomal Dominant Hypercholesterolemia Caused byPCSK9Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyCLINICAL PERSPECTIVE
- (2015) Paul N. Hopkins et al. Circulation-Cardiovascular Genetics
- Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes
- (2015) Traci Turner et al. CLINICAL THERAPEUTICS
- The hinterland of familial hypercholesterolaemia
- (2015) Anthony S. Wierzbicki et al. CURRENT OPINION IN LIPIDOLOGY
- Targeted next-generation sequencing in monogenic dyslipidemias
- (2015) Robert A. Hegele et al. CURRENT OPINION IN LIPIDOLOGY
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- The history of Autosomal Recessive Hypercholesterolemia (ARH). From clinical observations to gene identification
- (2015) Renato Fellin et al. GENE
- Prevalence and treatment of familial hypercholesterolaemia in Australian communities
- (2015) Gerald F. Watts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
- (2015) Joost Besseling et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cascade Screening in Familial Hypercholesterolemia: Advancing Forward
- (2015) Raul D. Santos et al. Journal of Atherosclerosis and Thrombosis
- Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
- (2015) P. Elliott Miller et al. Journal of Clinical Lipidology
- Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH)
- (2015) Sandro Muntoni et al. Journal of Clinical Lipidology
- Universal Screening for Familial Hypercholesterolemia in Children
- (2015) Gašper Klančar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of Autosomal Dominant Hypercholesterolemia Caused byPCSK9Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyCLINICAL PERSPECTIVE
- (2015) Paul N. Hopkins et al. Circulation-Cardiovascular Genetics
- Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia
- (2014) Jacques Genest et al. CANADIAN JOURNAL OF CARDIOLOGY
- AAV Vectors Expressing LDLR Gain-of-Function Variants Demonstrate Increased Efficacy in Mouse Models of Familial Hypercholesterolemia
- (2014) Suryanarayan Somanathan et al. CIRCULATION RESEARCH
- Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia
- (2014) Sigrid W. Fouchier et al. CIRCULATION RESEARCH
- Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries
- (2014) M. Futema et al. CLINICAL CHEMISTRY
- What is new in familial hypercholesterolemia?
- (2014) Raul D. Santos et al. CURRENT OPINION IN LIPIDOLOGY
- Recent advances in understanding the STSL locus and ABCG5/ABCG8 biology
- (2014) Shailendra B. Patel CURRENT OPINION IN LIPIDOLOGY
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolemia in China: Prevalence and evidence of underdetection and undertreatment in a community population
- (2014) Zumin Shi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
- (2014) Zanfina Ademi et al. Journal of Clinical Lipidology
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
- (2014) Ron Do et al. NATURE
- Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
- (2014) Gergana Galabova et al. PLoS One
- Familial Defective Apolipoprotein B and Familial Hypobetalipoproteinemia in One Family: Two Neutralizing Mutations
- (2013) Anouk van der Graaf et al. ANNALS OF INTERNAL MEDICINE
- Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia
- (2013) Nathan O. Stitziel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- APOE p.Leu167del mutation in familial hypercholesterolemia
- (2013) Zuhier Awan et al. ATHEROSCLEROSIS
- The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
- (2013) Gilbert R. Thompson ATHEROSCLEROSIS SUPPLEMENTS
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update
- (2013) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Lysosomal acid lipase A and the hypercholesterolaemic phenotype
- (2013) Sigrid W. Fouchier et al. CURRENT OPINION IN LIPIDOLOGY
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- (2013) Gerald F. Watts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
- (2013) Philippa J Talmud et al. LANCET
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- (2012) Frederick J. Raal et al. ATHEROSCLEROSIS
- Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study
- (2012) Roeland Huijgen et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia
- (2012) Sadik H. Kassim et al. HUMAN GENE THERAPY
- Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
- (2012) Marianne Benn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
- (2012) Asgeir Græsdal et al. Journal of Clinical Lipidology
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Being at risk for cardiovascular disease: Perceptions and preventive behavior in people with and without a known genetic predisposition
- (2012) L. Claassen et al. Psychology Health & Medicine
- Paediatric screening for hypercholesterolaemia in Europe: Table 1
- (2011) D M Kusters et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Psychological Issues in Genetic Testing for Inherited Cardiovascular Diseases
- (2011) Rajani D. Aatre et al. Circulation-Cardiovascular Genetics
- Assessment of Carotid Atherosclerosis in Normocholesterolemic Individuals With Proven Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes
- (2011) Roeland Huijgen et al. Circulation-Cardiovascular Genetics
- Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution
- (2011) Khemanganee E. Liyanage et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies
- (2011) L. Nherera et al. HEART
- Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- (2011) Matthew K. Ito et al. Journal of Clinical Lipidology
- Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- (2011) Stephen R. Daniels et al. Journal of Clinical Lipidology
- Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
- (2011) Jennifer G. Robinson et al. Journal of Clinical Lipidology
- Management of familial hypercholesterolemia during pregnancy: Case series and discussion
- (2011) Danny J. Eapen et al. Journal of Clinical Lipidology
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report
- (2011) PEDIATRICS
- Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial
- (2010) Roeland Huijgen et al. CLINICAL THERAPEUTICS
- Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia
- (2010) J. Rios et al. HUMAN MOLECULAR GENETICS
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma lipoproteins: genetic influences and clinical implications
- (2009) Robert A. Hegele NATURE REVIEWS GENETICS
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now